Edition:
United Kingdom

Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

5,360JPY
16 Aug 2019
Change (% chg)

¥35 (+0.66%)
Prev Close
¥5,325
Open
¥5,299
Day's High
¥5,371
Day's Low
¥5,291
Volume
542,200
Avg. Vol
897,030
52-wk High
¥11,320
52-wk Low
¥5,265

Select another date:

Fri, Mar 22 2019

Photo

Eisai starts phase 3 trials for second Alzheimer's drug after first's failure

TOKYO Eisai Co Ltd on Friday said it has begun phase 3 clinical trials of Alzheimer's treatment BAN2401, a day after the Japanese drugmaker and U.S. partner Biogen Inc scrapped trials for another Alzheimer's drug, aducanumab.

Nikkei falls as financials drag; Eisai indicated to dive

TOKYO, March 22 Japan's Nikkei fell in choppy trade on Friday as financial stocks languished, reflecting more cautious U.S. monetary policy, while the drug sector tumbled after Eisai and Biogen said they will end their Alzheimer's drug trials.

Biogen, Eisai scrap Alzheimer drug trials

March 21 Biogen Inc and Eisai Co Ltd said on Thursday they will discontinue two late-stage trials testing an experimental treatment for Alzheimer's disease.

Select another date: